首页>
外国专利>
Monoamine acridines for symptoms of deficiency in the cholinergic nervous system
Monoamine acridines for symptoms of deficiency in the cholinergic nervous system
展开▼
机译:单胺a啶治疗胆碱能神经系统缺乏症状
展开▼
页面导航
摘要
著录项
相似文献
摘要
A pharmaceutical composition for treatment of underlying nonpharmacologically induced central or peripheral nervous system cholinergic deficit state in humans comprising a monoamine acridine derivative of the formula: CHEM wherein R1 represents hydrogen, hydroxy, methyl, methoxy, ethyl or ethoxy; R1 and R2 together may form a double bond, R3 and R4 together may form a double bond, or R1, R2, R3 and R4 are all hydrogen; R5 represents hydrogen, hydroxy, methoxy or ethoxy; R6 represents hydrogen, hydroxy, methoxy or ethoxy; and R7 is without a substituent or R7 represents an oxygen atom, a C1-C20 alkyl radical or a radical selected from the group consisting of -R-N(R)2, CHEM wherein each R is independently selected from C1-C20 alkyl; or a pharmaceutically acceptable salts thereof, and a pharmaceutically acceptable inert carrier therefor; with the provisos that the monoamine acridine derivative is a compound in which (i) if R1, R2, R3, R4, R5 and R6 are each hydrogen, then R7 cannot be without a substituent, (ii) if R1 and R2 together form a double bond, R3 and R4 together form a double bond and R5 and R6 are each hydrogen, then R7 cannot be without a substituent, and (iii) if R3 and R4 together form a double bond and R7 is without a substituent, then R1 cannot be a hydrogen atom is provided. IMAGE
展开▼